Blog
Clinical evidence on the safety of NMN released recently
Clinical evidence on the safety of NMN released recently Researchers from Keio University and Washington...
Effepharm started new clinical trials on Uthever™ NMN
Effepharm started new clinical trials on Uthever™NMN Effepharm started our new clinical trials on UtheverTM NMN ingredient recently. According to...
Effepharm announced acquisitions and new R&D center establishment
Effepharm announced acquisitions and new R&D center establishment Effepharm acquired two bio-pharmaceutical companies recently, named Dendrimer...
Effepharm’s R&D Director got an outstanding achievement award for scientific research
Effepharm’s R&D Director got an outstanding achievement award for scientific research Dr. Jianjun Yu, Effepharm’s R&D Director, got an...
Branded NMN powder from Effepharm turns an instant hit at SupplySide West 2019
Branded NMN powder from Effepharm turns an instant hit at SupplySide West 2019 From 15th to 19th, Oct 2019, Effepharm attended the Supplyside West...
NMN ingredient of Effepharm made its debut at Hi Japan exhibition
NMN ingredient of Effepharm made its debut at Hi Japan exhibition From 2th to 4th, Oct 2019, Effepharm team participated in Hi Japan Exhibit, the...
Effepharm , the first NMN raw material manufacturer to do clinical trials
Effepharm , the first NMN raw material manufacturer to do clinical trials Clinical trials drive innovation and progress Which meansHigh-end brand...